This Month
- Opinion
- Chanticleer
Adieu: Ramsay Health Care’s shrinking global ambition
Under-pressure Ramsay Health Care is taking a fresh look at its footprint, which could mean a major change in its strategy. Watch this space.
- Anthony Macdonald
- Opinion
- Chanticleer
Private equity back to clean up its mess at troubled jobs agency
Jobs agency APM’s situation gets more bizarre as it goes looking for another frog to kiss.
- Anthony Macdonald
Andrew Thorburn lands CEO role at HammondCare
At his new job, the one-time NAB CEO’s Christianity is unlikely to be an issue.
- Myriam Robin
- Opinion
- Chanticleer
Ansell shows how to create new interest in an old story
Cheap stock never goes out of fashion. The key for a company is to issue it only occasionally, and make the most of when it does.
- Anthony Macdonald
Medtech Atmo Biosciences shop raise at $55m valuation
Alium Capital Management, Japanese pharmaceuticals giant Otsuka Pharmaceutical and Breakthrough Victoria are set to cornerstone Atmo Biosciences $15 million equity raise.
- Sarah Thompson, Kanika Sood and Emma Rapaport
March
- Opinion
- Chanticleer
Can a vaccine slow down the Cochlear train?
Cochlear is firing for investors, but you have to wonder whether everyone’s getting a bit carried away.
- Anthony Macdonald
Healius in management shake-up after CEO exit
Australia’s No.2 pathology group is cutting costs in a restructure to try to turn around a profit slump, as UBS pushes on with a strategic review.
- Simon Evans
Private equity group CVC walks away from $1.83b APM bid
Rich Lister Megan Wynne built APM from scratch in 1994 into a large player generating fees from helping people find jobs, and has expanded as an NDIS provider.
- Simon Evans
Blood giant CSL works up $US1 billion-plus bond deal; banks mandated
CSL has a host of top-tier investment banks working on the deal, namely Bank of America, Citi, JPMorgan and HSBC.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Healthscope lenders poised to appoint Houlihan Lokey amid restructure
Houlihan Lokey restructuring whiz Jim McKnight is expected to be appointed by lenders at Brookfield’s private hospitals group Healthscope.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Childcare giant G8’s $46m ‘no admission’ settlement
Even with insurance, shareholders will still take a hefty hit after the board decided to settle for “commercial” reasons.
- Updated
- Liam Walsh
Clarity Pharmaceuticals preps $110m raise; Bells, Wilsons mandated
Biotech Clarity Pharmaceuticals was warming up fund managers to launch a $110 million equity raising on Monday morning.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Healthscope lenders ready to bring out big guns as talks heat up
The lenders have sought pitches from Alvarez and Marsal, and AlixPartners, to work alongside Ashurst’s Shawn Wytenburg and James Marshall.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Chanticleer
The real story behind Healthscope’s restructure
As the Brookfield-owned Healthscope enters restructuring talks with its army of lenders, a much deeper crisis is playing out across the private hospital sector.
- Updated
- James Thomson
Founder-owned Menarock Life Aged Care hunts for strategic partner
Menarock is about half the size of Eccles family’s $40 million-a-year BlueCross Aged Care, recently sold to residential aged care operator Opal HealthCare.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Queensland private hospitals group Mater Health weighs its options
Sources said KordaMentha has been in-and-around the business, advising on things like business performance and financial modelling for individual hospitals.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Intermittent fasting may pose risks to your heart
A surprising new study has found that some intermittent fasters are more likely to die of heart disease.
- Updated
- Anahad O’Connor
Private equity group lifts Pacific Smiles bid to $279m
Genesis Capital has raised its buyout offer to $1.75 per share, from the $1.40 per share bid rejected in mid-December and the board is likely to recommend it to shareholders.
- Simon Evans
Chinese funds blow more than half a billion on Nature’s Care
Two state-owned private equity investors may have lost $585 million on Nature’s Care, a Sydney vitamins maker put into administration on Monday.
- Aaron Patrick
Brookfield’s Healthscope kicks off lender negotiations amid restructure
While it is early days yet, the situation is reminding sources of pet products business PetSmart’s recapitalisation in 2020.
- Sarah Thompson, Kanika Sood and Emma Rapaport